NDC 50090-0870
Truvada
Emtricitabine And Tenofovir Disoproxil Fumarate
Truvada is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Emtricitabine; Tenofovir Disoproxil Fumarate.
| Product ID | 50090-0870_450b081f-5e7e-4bcb-831d-09e70e281c34 |
| NDC | 50090-0870 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Truvada |
| Generic Name | Emtricitabine And Tenofovir Disoproxil Fumarate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2004-08-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021752 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
| Active Ingredient Strength | 200 mg/1; mg/1 |
| Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 50090-0870-0
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-0870-0)
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50090-0870-3 [50090087003]
Truvada TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA021752 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-11-28 |
| Marketing End Date | 2019-01-31 |
NDC 50090-0870-0 [50090087000]
Truvada TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA021752 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-11-28 |
| Marketing End Date | 2019-11-30 |
NDC 50090-0870-2 [50090087002]
Truvada TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA021752 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-11-28 |
| Marketing End Date | 2019-02-28 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| EMTRICITABINE | 200 mg/1 |
Pharmacological Class
- Nucleoside Analog [EXT]
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Nucleoside Analog [EXT]
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
NDC Crossover Matching brand name "Truvada" or generic name "Emtricitabine And Tenofovir Disoproxil Fumarate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 35356-070 | Truvada | emtricitabine and tenofovir disoproxil fumarate |
| 50090-0870 | Truvada | emtricitabine and tenofovir disoproxil fumarate |
| 52959-969 | Truvada | emtricitabine and tenofovir disoproxil fumarate |
| 53808-0805 | Truvada | emtricitabine and tenofovir disoproxil fumarate |
| 61919-669 | TRUVADA | emtricitabine and tenofovir disoproxil fumarate |
| 61958-0701 | Truvada | emtricitabine and tenofovir disoproxil fumarate |
| 68071-2112 | Truvada | Truvada |
| 69189-0701 | Truvada | Truvada |
| 70518-0097 | Truvada | Truvada |
| 61958-0704 | Truvada | Truvada |
| 61958-0705 | Truvada | Truvada |
| 61958-0703 | Truvada | Truvada |
| 63629-7581 | Truvada | Truvada |
| 67296-1237 | Truvada | Truvada |
| 0093-7607 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 0093-7704 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 0378-1930 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 0904-7172 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 16714-534 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate |
| 31722-560 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate |
| 33342-106 | Emtricitabine and tenofovir disoproxil fumarate | Emtricitabine and tenofovir disoproxil fumarate |
| 42291-439 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 42385-913 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 42385-953 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 42543-719 | Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE and TENOFOVIR Disoproxil Fumarate |
| 50090-5957 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE |
| 51407-112 | Emtricitabine and Tenofovir Disoproxil Fumarate | EMTRICITABINE and TENOFOVIR Disoproxil Fumarate |
| 60219-2092 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 60219-2093 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 60219-2094 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 60219-2095 | Emtricitabine and Tenofovir Disoproxil Fumarate | Emtricitabine and Tenofovir Disoproxil Fumarate |
| 60505-4202 | Emtricitabine and Tenofovir Disoproxil Fumarate | emtricitabine and tenofovir disoproxil fumarate |
Trademark Results [Truvada]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TRUVADA 78239720 2915213 Live/Registered |
Gilead Sciences, Inc. 2003-04-18 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.